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Age Education Diseaseduration MMSE
(raw)
1 AD F 49 10 4.8 14 Donepezil 10mg nocte N
2 AD M 53 10 3.9 23 Donepezil 10mg nocte N
3 AD M 56 16 3.4 28 Rivastigmine 6mg b.d. N
4 AD M 60 13 5.1 24 Donepezil 10mg nocte N
5 AD F 60 14 6.9 15 Donepezil 10mg nocte N
6 AD F 60 17 2.1 27 Donepezil 10mg nocte N
7 AD F 62 16 5.0 18 Donepezil 10mg nocte N
8 AD F 62 16 8.0 26 Donepezil 10mg nocte N
9 AD F 63 10 4.3 23 Donepezil 10mg nocte N
10 AD F 64 10 3.9 22 Donepezil 10mg nocte N
11 AD F 64 11 8.1 19 Donepezil 10mg nocte N
12 AD F 65 11 4.0 23 Donepezil 10mg nocte N
13 AD M 65 13 5.0 25 Donepezil 10mg nocte N
14 AD F 66 17 4.5 25 Donepezil 10mg nocte N
15 AD M 67 16 11.5 21 Memantine 10mg b.d. N
16 AD M 70 18 11.7 28 Donepezil 10mg nocte N
17 AD M 71 17 6.3 14 Memantine 10mg b.d. N
18 AD F 76 11 8.8 23 none N
19 AD F 77 17 4.8 25 Donepezil 5mg nocte N
20 AD M 80 9 6.6 22 Donepezil 10mg nocte N
21 AD M 76 12 5.9 19 Donepezil 10mg nocte N
22 PNFA F 59 16 6.0 14 none N
23 PNFA F 66 10 2.8 15 none N
24 PNFA F 67 10 4.0 19 none N
25 PNFA F 72 17 4.3 26 none N
26 PNFA F 77 10 4.3 22 none N
27 LPA M 57 14 3.9 11 none N
28 LPA M 62 13 2.8 6 Donepezil 10mg nocte N
29 LPA M 62 11 3.8 13 Donepezil 10mg nocte N
30 LPA M 64 10 4.0 6 Donepezil 10mg nocte N
31 LPA F 64 11 3.9 5 none N
32 LPA F 69 10 5.8 10 none N
33 LPA M 72 10 4.7 15 none N
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1 AD 98 62 120 -1.7 -1.7 -1.3 -2.3 -1.7 -3.0 -3.0 uta -1.8 -1.7 -2.7 -2.3 na
2 AD 78 58 67 -0.7 -1.7 -1.7 -2.0 -1.7 -3.0 -3.0 -3.0 -1.8 -1.7 -3.0 -2.3 na
3 AD 108 91 112 0.0 -1.3 1.5 0.4 3.0 1.0 1.0 1.0 2.3 1.5 -1.3 -0.3 na
4 AD 119 116 120 -1.7 -1.7 2.3 -0.8 -0.7 -1.7 -0.3 -0.7 -1.7 -1.5 -1.7 -1.3 na
5 AD 67 63 120 -1.7 -1.7 -2.7 -2.3 -1.7 -3.0 -3.0 -3.0 -1.7 -2.7 -2.7 -3.0 na
6 AD 88 67 100 -0.7 -1.7 -1.7 -2.3 -2.3 -3.0 -3.0 -3.0 0.0 -1.5 -2.7 -2.3 na
7 AD 94 62 104 -1.7 -1.7 -1.7 -2.3 -0.7 -3.0 -3.0 uta -1.0 -2.7 -2.7 -3.0 na
8 AD 130 118 127 -1.7 -0.7 0.7 0.6 0.7 0.3 0.7 -1.0 1.5 1.0 0.0 0.0 na
9 AD 106 99 96 -1.7 -1.3 -1.3 -1.0 0.7 -1.7 -1.0 -1.3 0.0 -1.0 -1.7 0.0 na
10 AD 98 81 109 -1.7 -1.7 -1.7 -1.4 -0.3 -3.0 -1.3 -1.0 0.0 -0.7 -0.3 -0.7 na
11 AD 109 97 120 -1.7 -1.7 0.7 0.0 0.7 0.3 0.7 0.3 0.0 1.5 -0.3 -1.3 na
12 AD 106 63 64 -1.7 -1.7 -2.7 -1.0 -2.3 -0.7 -1.3 -1.3 0.0 1.3 0.7 -0.7 na
13 AD 101 85 127 -1.7 -0.7 -0.7 -0.6 -0.7 -0.7 0.3 -1.7 1.3 0.6 1.0 -1.3 na
14 AD 121 109 120 -1.7 -1.7 0.0 -0.4 -0.3 -0.3 -0.3 -0.3 0.8 1.7 0.0 0.0 na
15 AD 118 105 120 -1.7 -0.7 0.0 -0.8 -1.3 0.7 -3.0 -2.3 -1.7 0.3 -1.0 -1.3 na
16 AD 116 97 127 0.7 0.0 1.5 -1.0 0.7 -0.7 0.3 -1.3 1.5 -0.7 -1.7 -0.3 na
17 AD 70 75 112 -1.3 0.7 -1.7 -2.3 0.3 -3.0 -3.0 -3.0 0.6 -0.3 -2.3 -3.0 na
18 AD 88 92 104 -1.7 -1.7 -1.7 -0.6 0.3 -1.3 -0.7 -3.0 0.3 0.7 -0.7 -1.0 na
19 AD 109 110 112 -1.7 -1.7 -1.7 0.2 0.3 -1.0 1.0 -0.3 0.8 0.7 0.7 -1.0 na
20 AD 86 85 98 -1.3 -0.7 -2.7 -1.6 -0.7 -3.0 -3.0 uta 0.6 -1.3 -1.0 -1.0 na
21 AD 113 99 120 -1.7 -1.7 0.0 -1.2 -0.3 -2.7 -1.0 -2.3 0.6 -1.3 -0.7 -0.3 na
22 PNFA 55 70 54 -0.7 -1.7 -2.7 -2.2 -0.7 -3.0 -3.0 uta -1.7 -2.7 -1.7 -2.3 1
23 PNFA 55 100 41 -1.7 -0.7 -2.7 -0.8 0.3 -0.3 -0.3 -2.7 -2.7 -1.7 -1.0 -0.7 0
24 PNFA 55 71 98 0.7 0.0 -2.7 -2.3 -1.7 -3.0 -3.0 uta -0.7 -1.7 -1.7 -1.7 20
25 PNFA 90 86 102 0.0 -1.3 0.7 -1.2 0.7 -3.0 -3.0 -3.0 0.8 -0.3 -0.7 0.7 9
26 PNFA 70 79 112 -1.7 -1.7 -1.7 -2.3 -2.3 -3.0 -3.0 uta -0.8 -2.3 -1.7 -1.7 na
27 LPA 55 76 41 -1.7 -1.7 -2.7 -2.3 -1.7 uta uta uta 0.6 -1.0 -2.3 -2.3 19
28 LPA 55 62 41 -1.7 -1.7 -2.7 -2.3 0.7 uta uta uta -1.7 -2.7 -2.7 -3.0 18
29 LPA 55 66 41 -1.7 -1.7 -2.7 -2.3 -2.3 uta uta uta -1.7 -2.7 -2.7 -2.3 na
30 LPA 55 71 41 -1.7 -1.7 -2.7 -2.3 0.7 uta uta uta -1.7 -1.5 -3.0 -3.0 15
31 LPA 55 65 81 -1.7 -1.7 -2.7 -2.3 -0.3 uta uta uta -1.7 -1.5 -2.0 -2.7 20
32 LPA 69 69 41 -1.7 -1.7 -2.7 -2.3 -1.7 -3.0 -3.0 -3.0 -0.7 -1.7 -1.7 -2.7 20
33 LPA 72 73 90 -1.7 -1.7 -2.7 -2.2 0.3 -3.0 -3.0 -3.0 -2.3 -2.3 -1.7 -2.3 na

























1 AD 20 20 20 20 18 28 39 0.3 - 0.5 0.2 -1.5 -3.5 0.5
2 AD 20 20 20 20 20 32 38 0.3 - 0.5 0.2 0.3 -2.0 -0.4
3 AD 20 20 20 20 20 30 38 0.3 - 0.5 0.2 0.3 -2.8 -0.4
4 AD 20 20 16 20 20 39 39 0.3 - -4.5 0.2 0.3 0.7 0.5
5 AD 15 19 19 19 14 37 34 -12.3 - -0.8 -1.8 -5.2 -0.1 -4.0
6 AD 18 18 19 16 20 25 39 -4.8 - -0.8 -7.8 0.3 -4.7 0.5
7 AD 20 15 20 17 14 23 33 0.3 - 0.5 -5.8 -5.2 -5.5 -4.9
8 AD 20 20 20 20 20 33 38 0.3 - 0.5 0.2 0.3 -1.6 -0.4
9 AD 18 12 14 20 19 27 40 -4.8 - -7.0 0.2 -0.6 -3.9 1.5
10 AD 20 20 19 20 20 35 37 0.3 - -0.8 0.2 0.3 -0.8 -1.3
11 AD 20 18 20 20 20 37 39 0.3 - 0.5 0.2 0.3 -0.1 0.5
12 AD 20 20 20 18 16 21 36 0.3 - 0.5 -3.8 -3.4 -6.2 -2.2
13 AD 17 19 20 20 20 31 37 -7.3 - 0.5 0.2 0.3 -2.4 -1.3
14 AD 20 20 20 20 20 33 39 0.3 - 0.5 0.2 0.3 -1.6 0.5
15 AD 20 20 20 20 16 26 40 0.3 - 0.5 0.2 -3.4 -4.3 1.5
16 AD 20 20 16 17 15 32 36 0.3 - -4.5 -5.8 -4.3 -2.0 -2.2
17 AD 20 20 20 20 20 38 40 0.3 - 0.5 0.2 0.3 0.3 1.5
18 AD 13 17 16 14 8 38 32 -17.3 - -4.5 -11.8 -10.6 0.3 -5.8
19 AD 20 20 20 20 20 36 38 0.3 - 0.5 0.2 0.3 -0.5 -0.4
20 AD 20 20 20 20 20 40 37 0.3 - 0.5 0.2 0.3 1.1 -1.3
21 AD 18 18 16 20 17 32 31 -4.8 - -4.5 0.2 -2.5 -2.0 -6.7
22 PNFA 10 13 12 14 15 29 30 -24.8 - -9.5 -11.8 -4.3 -3.2 -7.6
23 PNFA 16 16 11 18 20 39 26 -9.8 - -10.8 -3.8 0.3 0.7 -11.3
24 PNFA 20 17 16 20 20 27 35 0.3 - -4.5 0.2 0.3 -3.9 -3.1
25 PNFA 20 20 20 20 20 37 35 0.3 - 0.5 0.2 0.3 -0.1 -3.1
26 PNFA 20 20 19 20 20 39 33 0.3 - -0.8 0.2 0.3 0.7 -4.9
27 LPA 18 19 19 12 5 32 30 -4.8 - -0.8 -15.8 -13.4 -2.0 -7.6
28 LPA 13 10 11 17 21 29 -17.3 - -10.8 -5.8 -17.9 -6.2 -8.5
29 LPA 16 19 16 19 11 25 40 -9.8 - -4.5 -1.8 -7.9 -4.7 1.5
30 LPA 20 20 13 11 11 38 28 0.3 - -8.3 -17.8 -7.9 0.3 -9.5
31 LPA 19 18 19 20 20 37 36 -2.3 - -0.8 0.2 0.3 -0.1 -2.2
32 LPA 11 17 18 20 17 35 35 -22.3 - -2.0 0.2 -2.5 -0.8 -3.1
33 LPA 20 20 20 19 19 31 29 0.3 - 0.5 -1.8 -0.6 -2.4 -8.5









0.5 1 2 3 4 Unilateralhearing loss
1 AD + + + + + N N N N N
2 AD + + + + + N N N N N
3 AD L L L L + N N N N N
4 AD L L N N N N N
5 AD + + + + + N N N N N
6 AD L L L + N N N N N
7 AD + + + + + N N AN N AN
8 AD + + + + + N N N N N
9 AD + + + + + N N N N N
10 AD + N N AN AN AN right-sided
11 AD + + + + + + N N N N AN
12 AD + + + + + + N N N N N
13 AD L + L + + + N N N N N
14 AD + + N N N N N
15 AD + + + N N N N N
16 AD + + + + + N N N N AN
17 AD + + + + + + N N N N AN
18 AD + + + + + N N N AN AN
19 AD + + + + + + N N N N AN
20 AD + + + + + + N N N N N
21 AD ns ns ns ns ns ns N N N N N
22 PNFA + + + + + N N N N AN
23 PNFA L L L L L + N N N N N
24 PNFA + + + + + N N N N N
25 PNFA + + + + + N N N N N
26 PNFA + + + + + AN AN N AN AN
27 LPA L L L L L N N N N N
28 LPA + + + + + N N N N N
29 LPA L L L L L AN AN AN N N
30 LPA + + + + + N AN N N AN
31 LPA L + L + + N N N N N
32 LPA L L L L + N N N N N
33 LPA + + + + N N N AN N










Regional brain atrophy (see legend)
STG
1 Cannot calculate Z scores due to a lack of variability in the control sample
+ Bilateral atrophy with no strong asymmetry
AD Alzheimer's disease
AN Abnormal hearing at indicated frequency level (using normative data from Davis, 1995)
BPVS British Picture Vocabulary Scale (word-picture naming; Dunn et al., 1982)
GAA progranulin-associated aphasia
HG Heschl's gyrus
iTL inferior and middle temporal lobe
L Bilateral atrophy with more severe damage in the left hemisphere
LPA Logopenic (phonological) aphasia
mTL mesial temporal lobe




PNFA progressive non-fluent aphasia
PT planum temporale
RMT Recognition memory test (Warrington, 1984)
STG superior temporal gyrus (anterior to HG)
uta unable to attempt
VIQ verbal IQ
All MRI scans were assessed visually by a cognitive neurologist with extensive MRI experience (JW), who was
blinded to patients' clinical diagnoses and auditory performance. Six key cerebral regions implicated in auditory
processing (Heschl's gyrus, planum temporale, superior temporal gyrus anterior to Heschl's gyrus, inferior temporal
lobe, mesial temporal lobe, parietal lobe) were rated as either: unaffected (blank cell); atrophied bilaterally with no
strong asymmetry (+); atrophied bilaterally with more severe damage in the left or right hemisphere (L or R).
Davis, A. (1995). Hearing in adults: the prevalence and distribution of hearing impairment and reported hearing
disability in the MRC Institute of Hearing Research’s National Study of Hearing. London: Whurr Publishers.
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Legend (Regional brain atrophy)
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